The Hospitalist Channel
The Fink Tank: COVID-19 – Coronavirus Doesn’t Care Who You Voted For
COVID-19
Samuel I. Fink, MD, FACP, internal medicine specialist in private practice in Tarzana, California, and his daughter, Sarrica Fink, RN, previously in practice at Cedar Sinai Medical Center…
Healthcare Providers Are Not Immune to Mental Health Crises
COVID-19
Jenny C. Yip, PsyD, ABPP, shares advice for HCPs who may be struggling with anxiety or depression as a result of months of practicing medicine and managing personal…
Recent Videos in Hospitalist Page 102
Management of Closed Head Injuries
Critical Care
James P. Moises, MD, Assistant Clinical Professor of Surgery, Department of Emergency Medicine, Clerkship Director of Emergency Medicine, Tulane University Hospital and Clinic, discusses the management for closed…
HIV/AIDS Medication Non-Compliance and the Spread of HIV
Family Medicine
Ellen Tedaldi, MD, Professor of Internal Medicine, Director of HIV Program, Temple University School of Medicine, discusses non-compliance with HIVAIDS meds as well as ways to decrease the…
Different Types of Post-Mastectomy Breast Reconstructive Surgery
Family Medicine
Mary Wright, MD, Associate Professor & Director, Breast Center, Section of Breast Surgery, Department of Surgery, Tulane University School of Medicine, discusses post mastectomy breast reconstructive surgery. References…
Age-Related Macular Degeneration in Smokers and Non-Smokers
Family Medicine
This study observed how people who were current smokers, compared with those who never smoked, were at increased risk of incident early age-related macular degeneration (AMD) and for…
Approval from FDA: Natalizumab (Tysabri) for Tx of Mod-to-Severe Crohn’s
Family Medicine
The FDA has approved natalizumab (Tysabri) for the treatment of moderate-to-severe Crohn’s disease in patients with evidence of inflammation who have had an inadequate response to, or are…
Weekly Influenza Surveillance Report: 2/3 to 2/9/08
Influenza Content Hub
The CDC’s FluView, a weekly influenza surveillance report prepared by the influenza division, posts the statistics for influenza week 6, February 3 – February 9, 2008. References and…
Heparin Prophylaxis Using Low-molecular-weight heparin
Critical Care
Gilbert E. D’Alonzo, MD, Professor of Medicine, Temple University School of Medicine, discusses heparin prophylaxis. References and Resources Chibbaro S, Tacconi L. Safety of deep venous thrombosis prophylaxis…
Household Allergens
Allergy / Immunology
Steven G. Kelsen, MD, FACP, FCCP, Professor of Medicine, Microbiology, and Immunology, Temple University School of Medicine, discusses how one can try to alleviate household allergens. References and…
Status of Current Pediatric Emergency Care
Critical Care
James P. Moises, MD, Assistant Clinical Professor of Surgery, Department of Emergency Medicine, Clerkship Director of Emergency Medicine, Tulane University Hospital and Clinic, discusses pediatric emergency care. References…
From VerusMed Neurology February 11, 2008
Family Medicine
Impax Laboratories Inc. received a nonapprovable letter from the FDA regarding its New Drug Application and subsequent submissions for carbidopa/levodopa extended-release tablets. The FDA’s decision was primarily based…